|Articles|April 14, 2021
- Pharmaceutical Executive-04-01-2021
- Volume 41
- Issue 4
Pharmaceutical Executive, April 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive April 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
The Challenges of Worker Qualification Management in Pharmaover 5 years ago
Years in the Making: A Repeat Recognition—Uninterruptedover 5 years ago
Pharm Exec at 40 (1990-1993)over 5 years ago
The Power of Parityover 5 years ago
No Limits to Science, Or Selfover 5 years ago
In Silico in Sight as Biopharma Game-Changerover 5 years ago
Long-View Innovation Hopes for Pharma Policy in the EUAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
2
Legal Risk in a Rumored AstraZeneca-BMS Deal: Q&A with Ron Lanton
3
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million
4
Amazon Pharmacy Launches GLP-1 Delivery Service
5